CeriBell (CBLL) Competitors $15.38 -0.37 (-2.35%) As of 12:24 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock CBLL vs. EYE, LMAT, NVCR, SSII, ENOV, CNMD, CDRE, AORT, LQDA, and ESTAShould you be buying CeriBell stock or one of its competitors? The main competitors of CeriBell include National Vision (EYE), LeMaitre Vascular (LMAT), NovoCure (NVCR), SS Innovations International (SSII), Enovis (ENOV), CONMED (CNMD), Cadre (CDRE), Artivion (AORT), Liquidia Technologies (LQDA), and Establishment Labs (ESTA). These companies are all part of the "medical equipment" industry. CeriBell vs. Its Competitors National Vision LeMaitre Vascular NovoCure SS Innovations International Enovis CONMED Cadre Artivion Liquidia Technologies Establishment Labs National Vision (NASDAQ:EYE) and CeriBell (NASDAQ:CBLL) are both medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their valuation, earnings, dividends, institutional ownership, analyst recommendations, risk, media sentiment and profitability. Is EYE or CBLL more profitable? CeriBell has a net margin of 0.00% compared to National Vision's net margin of -1.40%. National Vision's return on equity of 3.44% beat CeriBell's return on equity.Company Net Margins Return on Equity Return on Assets National Vision-1.40% 3.44% 1.40% CeriBell N/A N/A N/A Which has better earnings & valuation, EYE or CBLL? National Vision has higher revenue and earnings than CeriBell. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNational Vision$1.82B1.10-$28.50M-$0.33-76.83CeriBell$65.44M8.48-$40.46MN/AN/A Does the media favor EYE or CBLL? In the previous week, National Vision had 7 more articles in the media than CeriBell. MarketBeat recorded 8 mentions for National Vision and 1 mentions for CeriBell. National Vision's average media sentiment score of 1.02 beat CeriBell's score of 0.00 indicating that National Vision is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National Vision 4 Very Positive mention(s) 2 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive CeriBell 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Do analysts rate EYE or CBLL? National Vision presently has a consensus target price of $23.00, indicating a potential downside of 9.29%. CeriBell has a consensus target price of $32.14, indicating a potential upside of 109.33%. Given CeriBell's stronger consensus rating and higher possible upside, analysts clearly believe CeriBell is more favorable than National Vision.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score National Vision 0 Sell rating(s) 4 Hold rating(s) 5 Buy rating(s) 0 Strong Buy rating(s) 2.56CeriBell 0 Sell rating(s) 0 Hold rating(s) 8 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryNational Vision beats CeriBell on 6 of the 11 factors compared between the two stocks. Get CeriBell News Delivered to You Automatically Sign up to receive the latest news and ratings for CBLL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CBLL and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CBLL vs. The Competition Export to ExcelMetricCeriBellMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$554.93M$10.36B$5.68B$9.50BDividend YieldN/A2.03%4.05%3.99%P/E RatioN/A17.3227.9520.00Price / Sales8.4827.51397.1083.19Price / CashN/A22.6936.1958.45Price / Book2.883.718.665.83Net Income-$40.46M$234.77M$3.24B$258.39M7 Day Performance-1.70%5.20%3.33%2.30%1 Month Performance-21.86%8.61%10.84%12.42%1 Year PerformanceN/A-1.64%35.32%21.16% CeriBell Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CBLLCeriBell2.0539 of 5 stars$15.36-2.5%$32.14+109.3%N/A$554.93M$65.44M0.00N/AEYENational Vision2.8195 of 5 stars$25.31+0.9%$22.10-12.7%+91.6%$1.98B$1.82B-76.6913,411Positive NewsAnalyst ForecastLMATLeMaitre Vascular2.7093 of 5 stars$79.82+0.1%$97.83+22.6%-8.8%$1.80B$219.86M40.31490Analyst ForecastNVCRNovoCure3.7055 of 5 stars$16.10+0.5%$32.43+101.4%-12.0%$1.79B$605.22M-10.661,488News CoverageEarnings ReportSSIISS Innovations InternationalN/A$8.40+5.9%N/AN/A$1.54B$20.65M0.004Gap UpENOVEnovis2.9345 of 5 stars$26.35+0.2%$55.60+111.0%-39.8%$1.50B$2.11B-1.897,367High Trading VolumeCNMDCONMED4.7569 of 5 stars$47.78+0.3%$62.20+30.2%-31.5%$1.47B$1.31B12.573,900Upcoming EarningsCDRECadre3.3772 of 5 stars$32.27-1.1%$37.50+16.2%-12.3%$1.33B$567.56M33.962,284Positive NewsDividend AnnouncementAORTArtivion2.9199 of 5 stars$30.63+0.5%$32.40+5.8%+11.8%$1.30B$388.54M-61.261,600News CoverageLQDALiquidia Technologies3.1787 of 5 stars$15.10+3.9%$26.89+78.1%+53.7%$1.24B$14M-9.5650News CoverageESTAEstablishment Labs2.0619 of 5 stars$42.60+2.5%$54.83+28.7%-10.1%$1.20B$166.02M-13.741,018Positive News Related Companies and Tools Related Companies National Vision Alternatives LeMaitre Vascular Alternatives NovoCure Alternatives SS Innovations International Alternatives Enovis Alternatives CONMED Alternatives Cadre Alternatives Artivion Alternatives Liquidia Technologies Alternatives Establishment Labs Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CBLL) was last updated on 7/24/2025 by MarketBeat.com Staff From Our PartnersGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredBREAKING: The House just passed 3 pro-crypto bills!Experts Believe Altcoin Season is Here! With this new legislation in effect, crypto experts across the coun...Crypto 101 Media | SponsoredFREE GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...GoldCo Precious Metals | SponsoredA new rule goes live in July — and the banks are quietly cashing inA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CeriBell, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CeriBell With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
